Health Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Eli Pacheco Apr 5, 2022 0 WASHINGTON -- Use of the potassium-binding agent patiromer (Veltassa) allowed more heart failure patients at risk for hyperkalemia…
